Stochastic modulation evidences a transitory EGF-Ras-ERK MAPK activity induced by PRMT5

The extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) pathway involves a three-step cascade of kinases that transduce signals and promote processes such as cell growth, development, and apoptosis. An aberrant response of this pathway is related to the proliferation of cell diseases and tumors. By using simulation modeling, we document that the protein arginine methyltransferase 5 (PRMT5) modulates the MAPK pathway and thus avoids an aberrant behavior. PRMT5 methylates the Raf kinase, reducing its catalytic activity and thereby, reducing the activation of ERK in time and amplitude. Two minimal computational models of the epidermal growth factor (EGF)-Ras-ERK MAPK pathway influenced by PRMT5 were proposed: a first model in which PRMT5 is activated by EGF and a second one in which PRMT5 is stimulated by the cascade response. The reported results show that PRMT5 reduces the time duration and the expression of the activated ERK in both cases, but only in the first model PRMT5 limits the EGF range that generates an ERK activation. Based on our data, we propose the protein PRMT5 as a regulatory factor to develop strategies to fight against an excessive activity of the MAPK pathway, which could be of use in chronic diseases and cancer.

[1]  S. Richard,et al.  Loss of PRMT5 Promotes PDGFRα Degradation during Oligodendrocyte Differentiation and Myelination. , 2018, Developmental cell.

[2]  Li-Jen Su,et al.  Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin‐dependent kinases and the phosphoinositide 3‐kinase/AKT signaling cascade , 2012, Cancer science.

[3]  Alexander Hoffmann,et al.  Understanding the temporal codes of intra-cellular signals. , 2010, Current opinion in genetics & development.

[4]  D. Polsky,et al.  Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues. , 2003, Cancer research.

[5]  William S. Hlavacek,et al.  Relaxation oscillations and hierarchy of feedbacks in MAPK signaling , 2017, Scientific Reports.

[6]  D. Gillespie.  Exact Stochastic Simulation of Coupled Chemical Reactions , 1977 .

[7]  G. Meister,et al.  Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln , 2001, Current Biology.

[8]  Steven Clarke,et al.  PRMT5 (Janus Kinase-binding Protein 1) Catalyzes the Formation of Symmetric Dimethylarginine Residues in Proteins* , 2001, The Journal of Biological Chemistry.

[9]  Sharmistha Pal,et al.  Human SWI/SNF-Associated PRMT5 Methylates Histone H3 Arginine 8 and Negatively Regulates Expression of ST7 and NM23 Tumor Suppressor Genes , 2004, Molecular and Cellular Biology.

[10]  Philippe P Roux,et al.  Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases , 2011, Microbiology and Molecular Reviews.

[11]  Chang-Hai Tsai,et al.  Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation , 2011, Nature Cell Biology.

[12]  Xinbin Chen,et al.  PRMT5 is required for cell-cycle progression and p53 tumor suppressor function , 2009, Nucleic acids research.

[13]  Alma L. Burlingame,et al.  A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK , 2011, Nature.

[14]  Sharmistha Pal,et al.  Protein Arginine Methyltransferase 5 Suppresses the Transcription of the RB Family of Tumor Suppressors in Leukemia and Lymphoma Cells , 2008, Molecular and Cellular Biology.

[15]  J. Blenis,et al.  ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions , 2004, Microbiology and Molecular Biology Reviews.

[16]  Ulf Reimer,et al.  Histone H2A and H4 N-terminal Tails Are Positioned by the MEP50 WD Repeat Protein for Efficient Methylation by the PRMT5 Arginine Methyltransferase* , 2015, The Journal of Biological Chemistry.

[17]  Ximing J. Yang,et al.  The expression and function of androgen receptor coactivator p44 and protein arginine methyltransferase 5 in the developing testis and testicular tumors. , 2007, The Journal of urology.

[18]  U. Bhalla,et al.  Emergent properties of networks of biological signaling pathways. , 1999, Science.

[19]  D. Shechter,et al.  A TGFβ-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression , 2016, Oncogene.

[20]  Walter Kolch,et al.  When ubiquitination meets phosphorylation: a systems biology perspective of EGFR/MAPK signalling , 2013, Cell Communication and Signaling.

[21]  I. Treilleux,et al.  LKB1 regulates PRMT5 activity in breast cancer , 2018, International journal of cancer.

[22]  K. Søreide,et al.  EGFR and downstream genetic alterations in KRAS/BRAF and PI3K/AKT pathways in colorectal cancer: implications for targeted therapy. , 2012, Discovery medicine.

[23]  Ming Zhou,et al.  Regulation of Raf-1 by direct feedback phosphorylation. , 2005, Molecular cell.

[24]  Ruth Nussinov,et al.  Raf-1 Cysteine-Rich Domain Increases the Affinity of K-Ras/Raf at the Membrane, Promoting MAPK Signaling. , 2018, Structure.

[25]  Kazuhiro Aoki,et al.  Multiple Decisive Phosphorylation Sites for the Negative Feedback Regulation of SOS1 via ERK* , 2010, The Journal of Biological Chemistry.

[26]  I. Lossos,et al.  PRMT5-mediated histone arginine methylation antagonizes transcriptional repression by polycomb complex PRC2 , 2020, Nucleic acids research.

[27]  Chi-Ying F. Huang,et al.  Ultrasensitivity in the mitogen-activated protein kinase cascade. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L. Rui,et al.  PRMT5 in gene regulation and hematologic malignancies , 2019, Genes & diseases.

[29]  B. Manwani,et al.  Inhibition of mitogen-activated protein kinase phosphatase-1 (MKP-1) increases experimental stroke injury , 2014, Experimental Neurology.

[30]  Yosef Yarden,et al.  Feedback regulation of EGFR signalling: decision making by early and delayed loops , 2011, Nature Reviews Molecular Cell Biology.

[31]  D. Hammer,et al.  Integrin-mediated signalling through the MAP-kinase pathway. , 2008, IET systems biology.

[32]  X. Cen,et al.  Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3 , 2015, Oncotarget.

[33]  S. Clarke,et al.  Protein arginine methylation in mammals: who, what, and why. , 2009, Molecular cell.

[34]  R. Bernards,et al.  RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells. , 2014, Cell reports.

[35]  Tianhai Tian,et al.  Plasma membrane nanoswitches generate high-fidelity Ras signal transduction , 2007, Nature Cell Biology.

[36]  J. Grandis,et al.  Signaling through the epidermal growth factor receptor during the development of malignancy. , 2004, Pharmacology & therapeutics.

[37]  P. Crespo,et al.  ERK Signals: Scaffolding Scaffolds? , 2016, Front. Cell Dev. Biol..

[38]  M. Herlyn,et al.  Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase. , 2010, Cancer cell.

[39]  Susan S. Taylor,et al.  Kinases and Pseudokinases: Lessons from RAF , 2014, Molecular and Cellular Biology.

[40]  D. Gillespie.  A General Method for Numerically Simulating the Stochastic Time Evolution of Coupled Chemical Reactions , 1976 .

[41]  Kwang-Hyun Cho,et al.  Positive- and negative-feedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway , 2009, Journal of Cell Science.

[42]  Q. Fan,et al.  The ubiquitin system: orchestrating cellular signals in non-small-cell lung cancer , 2020, Cellular & Molecular Biology Letters.

[43]  Muffy Calder,et al.  The Mammalian MAPK/ERK Pathway Exhibits Properties of a Negative Feedback Amplifier , 2010, Science Signaling.

[44]  M. Tomita,et al.  Conversion of graded phosphorylation into switch-like nuclear translocation via autoregulatory mechanisms in ERK signalling , 2016, Nature Communications.

[45]  M. Baccarini,et al.  Raf kinases in cancer–roles and therapeutic opportunities , 2011, Oncogene.

[46]  Tyler E. Miller,et al.  Methylation of histone H3 and H4 by PRMT5 regulates ribosomal RNA gene transcription , 2009, Journal of cellular biochemistry.

[47]  Y. Zhong,et al.  Role of protein arginine methyltransferase 5 in human cancers. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[48]  R. Bradshaw,et al.  Early changes in protein synthesis induced by basic fibroblast growth factor, nerve growth factor, and epidermal growth factor in PC12 pheochromocytoma cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Downward.  Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[50]  Min Liu,et al.  PRMT5 suppresses DR4-mediated CCL20 release via NF-κB pathway , 2012 .

[51]  K. Morgan,et al.  Hierarchical scaffolding of an ERK1/2 activation pathway , 2013, Cell Communication and Signaling.

[52]  Jeremiah D. Keyes,et al.  Signaling diversity enabled by Rap1-regulated plasma membrane ERK with distinct temporal dynamics , 2019, bioRxiv.

[53]  Rasika Mundade,et al.  PRMT5, A Pivotal Player in Cancer , 2014 .

[54]  H. Hang,et al.  A role for the arginine methylation of Rad9 in checkpoint control and cellular sensitivity to DNA damage , 2011, Nucleic acids research.

[55]  S. Clarke,et al.  RNA and protein interactions modulated by protein arginine methylation. , 1998, Progress in Nucleic Acid Research and Molecular Biology.

[56]  David B. Pettigrew,et al.  Dynamic Properties of Regulatory Motifs Associated with Induction of Three Temporal Domains of Memory in Aplysia , 2005, Journal of Computational Neuroscience.

[57]  S. Keyse,et al.  Dual-specificity MAP kinase phosphatases (MKPs) , 2013, The FEBS journal.

[58]  Daniel T Gillespie,et al.  Stochastic simulation of chemical kinetics. , 2007, Annual review of physical chemistry.

[59]  A. Mackensen,et al.  Selective PRMT5 Inhibitors Suppress Human CD8+ T Cells by Upregulation of p53 and Impairment of the AKT Pathway Similar to the Tumor Metabolite MTA , 2019, Molecular Cancer Therapeutics.

[60]  J. Hussain,et al.  CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation. , 2008, Molecular cell.

[61]  Ming Li,et al.  The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLARL in human lung cancer cells , 2019, Journal of Experimental & Clinical Cancer Research.

[62]  Monika Heiner,et al.  Rare Event Handling in Signalling Cascades , 2014 .

[63]  Shinya Kuroda,et al.  Prediction and validation of the distinct dynamics of transient and sustained ERK activation , 2005, Nature Cell Biology.

[64]  K. Irie,et al.  Dynamics and organization of MAP kinase signal pathways , 1995, Molecular reproduction and development.

[65]  Mark T Bedford,et al.  Arginine methylation an emerging regulator of protein function. , 2005, Molecular cell.

[66]  S. Malek,et al.  Targeting the MAPK Pathway in RAS Mutant Cancers. , 2018, Cold Spring Harbor perspectives in medicine.

[67]  Yasushi Sako,et al.  Optimality Conditions for Cell-Fate Heterogeneity That Maximize the Effects of Growth Factors in PC12 Cells , 2013, PLoS Comput. Biol..

[68]  T. Shiomi,et al.  Inhibition of MKP-1 expression potentiates JNK related apoptosis in renal cancer cells. , 2004, The Journal of urology.

[69]  Sharmistha Pal,et al.  Low levels of miR‐92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma , 2007, The EMBO journal.

[70]  S. Richard,et al.  Arginine methylation regulates IL-2 gene expression: a role for protein arginine methyltransferase 5 (PRMT5). , 2005, The Biochemical journal.

[71]  G. Lahav,et al.  Encoding and Decoding Cellular Information through Signaling Dynamics , 2013, Cell.

[72]  J. Hancock,et al.  Activation of the MAPK module from different spatial locations generates distinct system outputs. , 2008, Molecular biology of the cell.

[73]  Paola Lecca.  Stochastic chemical kinetics , 2013, Biophysical Reviews.

[74]  G. Bae,et al.  PRMT5 promotes DNA repair through methylation of 53BP1 and is regulated by Src-mediated phosphorylation , 2020, Communications Biology.

[75]  Channing J Der,et al.  Increasing complexity of Ras signaling , 1998, Oncogene.

[76]  Y. Pommier,et al.  PRMT5-mediated arginine methylation of TDP1 for the repair of topoisomerase I covalent complexes , 2018, Nucleic acids research.

[77]  Murat Cirit,et al.  Systematic Quantification of Negative Feedback Mechanisms in the Extracellular Signal-regulated Kinase (erk) Signaling Network * □ S Experimental Procedures Data-driven Modeling of Feedback Regulating Erk Signaling Data-driven Modeling of Feedback Regulating Erk Signaling Data-driven Modeling of Fee , 2022 .

[78]  Hong Zhang,et al.  Arginine methylation modulates autophagic degradation of PGL granules in C. elegans. , 2013, Molecular cell.

[79]  S. Keyse,et al.  The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs) , 2016, Seminars in cell & developmental biology.

[80]  M. Cobb,et al.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.

[81]  M. Jansson,et al.  Arginine methylation regulates the p53 response , 2008, Nature Cell Biology.

[82]  S. Nimer,et al.  Arginine methyltransferases in normal and malignant hematopoiesis. , 2016, Experimental hematology.

[83]  Soo-Hyun Park,et al.  Activation of PRMT1 and PRMT5 mediates hypoxia- and ischemia-induced apoptosis in human lung epithelial cells and the lung of miniature pigs: the role of p38 and JNK mitogen-activated protein kinases. , 2013, Biochemical and biophysical research communications.

[84]  Chonglin Yang,et al.  Caenorhabditis elegans Protein Arginine Methyltransferase PRMT-5 Negatively Regulates DNA Damage-Induced Apoptosis , 2009, PLoS genetics.

[85]  C. McArdle,et al.  ERK phosphorylation and nuclear accumulation: insights from single-cell imaging. , 2012, Biochemical Society transactions.

[86]  S. Wolf.  The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humans , 2009, Cellular and Molecular Life Sciences.

[87]  P. Cohen,et al.  Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. , 1992, The Biochemical journal.

[88]  Zhengxin Wang,et al.  Protein Arginine Methyltransferase 5 Functions in Opposite Ways in the Cytoplasm and Nucleus of Prostate Cancer Cells , 2012, PloS one.

[89]  N. Rosen,et al.  V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[90]  Yu Zhao,et al.  The Mechanism of Dephosphorylation of Extracellular Signal-regulated Kinase 2 by Mitogen-activated Protein Kinase Phosphatase 3* , 2001, The Journal of Biological Chemistry.

[91]  Pamela A. Silver,et al.  State of the Arg Protein Methylation at Arginine Comes of Age , 2001, Cell.

[92]  Claudio Agostinelli,et al.  Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation. , 2015, Blood.

[93]  A. Deblasio,et al.  JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation. , 2011, Cancer cell.

[94]  J. Luengo,et al.  Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors , 2019, ACS medicinal chemistry letters.

[95]  E. Gilles,et al.  Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors , 2002, Nature Biotechnology.

[96]  B. Kholodenko,et al.  Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades. , 2000, European journal of biochemistry.

[97]  N. Ahn,et al.  Signal transduction through MAP kinase cascades. , 1998, Advances in cancer research.

[98]  B. Illi,et al.  Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells , 2015, Scientific Reports.

[99]  Lester G. Carter,et al.  Correction: Structure of the Arginine Methyltransferase PRMT5-MEP50 Reveals a Mechanism for Substrate Specificity , 2013, PLoS ONE.

[100]  Negative feedback self-regulation contributes to robust and high-fidelity transmembrane signal transduction , 2012, Journal of The Royal Society Interface.

[101]  Kunio Kondoh,et al.  The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity , 2005, Journal of Cell Science.

[102]  Z. Fuks,et al.  Downregulation of KSR1 in pancreatic cancer xenografts by antisense oligonucleotides correlates with tumor drug uptake , 2008, Cancer biology & therapy.

[103]  Jiaoti Huang,et al.  PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair Genes , 2019, iScience.

[104]  D. Fell,et al.  Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells , 2000, FEBS letters.

[105]  Walter Kolch,et al.  Identification of the Mechanisms Regulating the Differential Activation of the MAPK Cascade by Epidermal Growth Factor and Nerve Growth Factor in PC12 Cells* , 2001, The Journal of Biological Chemistry.

[106]  Z. Ronai,et al.  PRMT5 function and targeting in cancer , 2020, Cell stress.

[107]  M. Bedford,et al.  Arginine methylation at a glance , 2007, Journal of Cell Science.

[108]  Robert E. Lewis,et al.  AMPK Promotes Aberrant PGC1β Expression To Support Human Colon Tumor Cell Survival , 2015, Molecular and Cellular Biology.

[109]  M. Stallcup,et al.  Minireview: protein arginine methylation of nonhistone proteins in transcriptional regulation. , 2009, Molecular endocrinology.

[110]  G. Merlino,et al.  Protein Arginine Methyltransferase 5 Regulates ERK1/2 Signal Transduction Amplitude and Cell Fate Through CRAF , 2011, Science Signaling.

[111]  A. Richters.  Targeting protein arginine methyltransferase 5 in disease. , 2017, Future medicinal chemistry.

[112]  Y. Ke,et al.  Ginkgolides mimic the effects of hypoxic preconditioning to protect C6 cells against ischemic injury by up-regulation of hypoxia-inducible factor-1 alpha and erythropoietin. , 2008, The international journal of biochemistry & cell biology.

[113]  S. Wiese,et al.  B- and C-RAF Display Essential Differences in Their Binding to Ras , 2007, Journal of Biological Chemistry.

[114]  W. Shih,et al.  Detection of B-RAF and N-RAS mutations in human melanoma. , 2005, Journal of the American College of Surgeons.